Abstract

Patients with cancer have a high incidence of venous thromboembolism (VTE). It is estimated that fifteen percent of patients with carcinoma develop VTE (1). Sarcoma patients have a similar incidence of VTE (2). Patients undergoing major orthopedic procedures are also at increased risk for developing VTE.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call